The Small Cell Lung Cancer Therapeutics Market continues to evolve as oncology researchers and pharmaceutical developers intensify efforts to address the aggressive biology and limited treatment options characteristic of this challenging malignancy. With small cell lung cancer representing approximately 15% of all lung cancer diagnoses and maintaining a notoriously poor prognosis due to rapid...